122 related articles for article (PubMed ID: 25656312)
1. Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study.
Kaapu KJ; Ahti J; Tammela TL; Auvinen A; Murtola TJ
Int J Cancer; 2015 Sep; 137(5):1187-95. PubMed ID: 25656312
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.
Kaapu KJ; Murtola TJ; Määttänen L; Talala K; Taari K; Tammela TL; Auvinen A
Cancer Causes Control; 2016 Feb; 27(2):157-64. PubMed ID: 26573846
[TBL] [Abstract][Full Text] [Related]
3. Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men.
Kaapu KJ; Rantaniemi L; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Sci Rep; 2018 Jul; 8(1):10308. PubMed ID: 29985440
[TBL] [Abstract][Full Text] [Related]
4. Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer.
Kaapu KJ; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
Br J Cancer; 2016 Nov; 115(11):1289-1295. PubMed ID: 27755533
[TBL] [Abstract][Full Text] [Related]
5. The association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case-control study.
Kemppainen KJ; Tammela TL; Auvinen A; Murtola TJ
Cancer Causes Control; 2011 Oct; 22(10):1445-52. PubMed ID: 21769492
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
[TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drugs with histone deacetylase inhibition activity and prostate cancer risk: a population-based case-control study.
Salminen JK; Tammela TL; Auvinen A; Murtola TJ
Cancer Causes Control; 2016 May; 27(5):637-45. PubMed ID: 27038166
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic drug usage and prostate cancer: a population-based cohort study.
Kao LT; Huang CC; Lin HC; Huang CY
Asian J Androl; 2018; 20(1):37-42. PubMed ID: 28857052
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic medication and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Am J Epidemiol; 2008 Oct; 168(8):925-31. PubMed ID: 18700234
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
11. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
12. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level.
Veitonmäki T; Tammela TL; Auvinen A; Murtola TJ
Eur J Cancer; 2013 Mar; 49(4):938-45. PubMed ID: 23079475
[TBL] [Abstract][Full Text] [Related]
13. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
Mason JW
N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
Murtola TJ; Tammela TL; Määttänen L; Huhtala H; Platz EA; Ala-Opas M; Stenman UH; Auvinen A
Int J Cancer; 2010 Oct; 127(7):1650-9. PubMed ID: 20073066
[TBL] [Abstract][Full Text] [Related]
15. A cohort study of digoxin exposure and mortality in men with prostate cancer.
Flahavan EM; Sharp L; Bennett K; Barron TI
BJU Int; 2014 Feb; 113(2):236-45. PubMed ID: 23937513
[TBL] [Abstract][Full Text] [Related]
16. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
17. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
[TBL] [Abstract][Full Text] [Related]
19. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
